Core Viewpoint - The prolonged U.S. government shutdown is significantly hindering companies hoping to go public by the end of the year, as the SEC's review of filings is stalled, leaving these companies with limited options to proceed with their IPOs [1][2]. Group 1: Impact on IPOs - Companies that applied for IPOs in September or October, such as Andersen Group, Medline, and Wealthfront, were likely aiming for a listing before Thanksgiving but are now facing delays due to the shutdown [1]. - The shutdown has lasted nearly two months, causing these companies to miss the opportunity to utilize the SEC's automatic effectiveness provisions, which would have allowed them to set issuance terms and start a 20-day countdown to automatic effectiveness [1]. - The ability of companies to adjust issuance terms based on market demand remains limited, leading to relatively high IPO discount rates [1]. Group 2: Market Reactions - The market has tested the resolve of some companies, with Navan's stock dropping by up to 36% since its IPO on October 30, while MapLight Therapeutics' stock has hovered around its IPO price [1]. - Beta Technologies experienced a decline on its first day of trading but saw some recovery afterward [1]. Group 3: Future Outlook - Companies confident that their IPO applications are complete may find the automatic effectiveness route beneficial, but they must ensure there are no significant misstatements or omissions [2]. - Companies that began preparing for an IPO earlier in 2025 may still have a chance to go public this year, but those awaiting substantial SEC feedback are likely to delay until next year, especially with the holidays approaching [2]. - If the government shutdown continues indefinitely, companies intending to use the automatic effectiveness route will likely see their IPO timelines pushed to after Thanksgiving, a period generally unfavorable for IPOs due to investor travel and holidays [2]. Group 4: SEC Review Process - Once the SEC reopens, a backlog of applications is expected, and the agency may not respond as quickly as usual to resubmissions [3].

Core Insights - The low-altitude economy is gaining traction, with Volant Aviation, a Shanghai-based eVTOL company, recently securing significant funding for its electric vertical takeoff and landing aircraft [1][6] - Volant Aviation focuses on passenger transport, distinguishing itself from other eVTOL companies like Zero Gravity, which has different applications [1] - The eVTOL market is expected to see small-scale commercial operations in major Chinese cities, with an estimated 200 units per year over the next five years [2] Company Overview - Volant Aviation was founded by Dong Ming, who has a background in aviation projects such as ARJ21 and C919 [3][4] - The company has rapidly progressed in funding, completing six rounds of financing totaling approximately 1 billion yuan by 2024 [6] - Volant has secured its first confirmed orders for the VE25-100 model eVTOL, marking a significant milestone in China's commercial passenger eVTOL sector [6] Technology and Applications - eVTOL technology includes multi-rotor, tilt-rotor, and compound wing designs, each with distinct advantages and disadvantages [10][12] - Volant Aviation employs a combination of tilt-rotor and modular technology for its aircraft [15] - The primary applications for eVTOLs include low-altitude tourism, intercity transport, emergency rescue, and medical supply delivery [16][20][23] Market Potential - Volant Aviation has received substantial orders from various companies, including a notable order of 500 VE25-100 eVTOLs from Thailand's Pan-Pacific [17] - The eVTOL market in China is projected to capture 25-30% of the global market share by 2030, with an anticipated demand of around 500 units annually from 2025 to 2030 [23][24]